Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPERIA: Neo-adjuvant Brachytherapy Followed by Nivolumab in Rectal Cancer
NCT07645118Phase 2Recruiting
- Sponsor
- Dr. Te Vuong
- Start
- Oct 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 2 trial of nivolumab in rectal cancer, sponsored by Dr. Te Vuong. Started Oct 2026; status: recruiting.
02
Drugs
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT07645118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07645118.